Approval · Notice of Compliance 19629 · 2017
TOMUDEX: Notice of Compliance 19629
Issued August 8, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19629
- Date
- August 8, 2017
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOMUDEX | 02229566 | Marketed |
Medicinal ingredients
- RALTITREXED DISODIUM 2 MG per VIAL